Delivery Order SPE2DB20D1051-SPE2DB24FD7QY
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,097.08, has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $1,908.62, is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a single-award IDC valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Delivery Order contract worth $17,278.79 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This Delivery Order contract has a firm fixed price and an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The single-award Indefinite Delivery Contract (IDC), valued up to $999,999,999.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen as the prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,522.94 and a completion date of June 18, 2024. It is a Delivery Order with a Firm Fixed Price pricing type, covering the supply of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a Delivery Order valued at $2,495.95 for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award was made by the Defense Logistics Agency (DLA), which is a defense agency, for fulfillment by May 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, as well as a smaller IDC with the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,768.89 firm-fixed-price delivery order is for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,097.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a completion date of March 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,131.02 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $22,103.24 firm fixed price delivery order is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a completion date of June 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD7QYDelivery Order
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $3,486.62 and an ultimate completion date of April 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/8/24 |